Advertisement

Topics

Approval for Listing of Shares of Solasia on the Tokyo Stock Exchange Mothers

01:00 EST 21 Feb 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Solasia Pharma K.K. (Headquarters: Tokyo, Japan, President and CEO: Yoshihiro Arai, hereinafter “Solasia”) an oncology specialized pharmaceutical company developing oncology products for Asian commercial markets, announced t...

Other Sources for this Article

for Solasia Pharma K.K.
Rie Toyoda, +81-3-6721-8317
Investors Relations

NEXT ARTICLE

More From BioPortfolio on "Approval for Listing of Shares of Solasia on the Tokyo Stock Exchange Mothers"

Advertisement
Quick Search
Advertisement
Advertisement